Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Technology Potential, Competitive Market Share & Forecast, 2018 - 2024

Published Date: Dec 2018 | 150 Pages | Report ID: GMI3033 | Authors: Sumant Ugalmugale Report Format: PDF

  Request Sample Inquiry Before Buying
Summary Table of Contents Industry Coverage Methodology Customize this Report

Industry Trends

Direct-to-Consumer Genetic Testing Market size was valued at USD 601.5 million in 2017 and is expected to witness more than 18% CAGR from 2018 to 2024.

India Direct-to-Consumer Genetic Testing Market, By Test Type, 2017 & 2024 (USD Million)
 India DTC Genetic Testing Market, By Test Type, 2017 & 2024 (USD Million)

Get more details on this report - Request Free Sample PDF

Increasing prevalence of genetic diseases such as cancer worldwide is the key factor driving global direct-to-consumer genetic testing industry growth. According to Global Genes, around 350 million people worldwide suffer from genetic and rare diseases. Direct-to-consumer genetic tests enable consumers to identify genetic predisposition to several genetic diseases. Rising adoption of DTC genetic testing for early disease detection and identification of genetic mutation preceding its manifestation will further accelerate the DTC genetic testing business growth over the forecast timeline.

Growing patient demand for service personalization in developed economies such as North America and Europe will boost the demand for DTC genetic testing for detection of various genetic and rare diseases during the forecast period. Demand for service personalization to provide tailored medical treatment to individual patient based on their molecular basis is increasing in recent years. This reduces the risk of potential negative side effects triggered by medicines and treatments by prescribing medication specific to individual’s genetic makeup.

Moreover, adoption of DTC genetic testing to identify ancestral origins and explore them to undertake a precautionary preparation for healthcare and promote knowledge of genetic diseases will further spur the industry size. However, high cost of DTC genetic testing may hamper the industry growth to some extent in developing and under developed countries. Furthermore, defects in the testing kits that increase the risk associated with incorrect interpretations may further render negative impact on the DTC genetic testing industry growth. 

Direct-to-Consumer Genetic Testing Market, By Test Type

DTC predictive testing segment accounted for USD 110.8 million revenue in 2017 and is expected to witness significant growth over the analysis timeframe. Ability of predictive tests to provide information regarding likelihood of acquiring certain diseases at a later stage in life increases its adoption among the consumers. Increasing awareness among people pertaining to early disease detection to undergo timely treatment and minimize the severity of diseases will further foster segment growth in the coming years.

DTC carrier testing segment is projected to show robust growth with a CAGR of 19.8% during the forecast period. Carrier testing is primarily done before or during pregnancy to determine whether an individual is a carrier of certain genetic disorders. As per the Centers for Disease Control and Prevention (CDC), each year about 3% of all the new-borns in the U.S. are affected by some or other birth defects resulting in infant mortality. This will increase the adoption of carrier testing among the pregnant women, to determine the risks of  child inheriting one of genetic disorders after birth, thereby augmenting the segment growth.

Germany DTC Genetic Testing Market Size, By Technology, 2017 (USD Million)
Germany DTC Genetic Testing Market Size, By Technology, 2017 (USD Million)

Get more details on this report - Request Free Sample PDF


 Direct-to-Consumer Genetic Testing Market, By Technology

Single nucleotide polymorphism (SNP) chips segment will grow at a CAGR of 18.6% during the forecast years owing to rising prevalence of chronic and rare diseases across the globe. Growing reliance on SNP chips due to its ability to target approximately 1 million sites of known genetic variation will spur the market size in the coming years. Increasing usage of SNP chips to provide information about risk for common and rare diseases is expected to escalate the segment growth during the analysis period.

Whole genome sequencing (WGS) segment was valued at USD 77.8 million revenue in 2017 and will witness considerable growth by 2024. The segment growth is attributed to the ability of whole genome sequencing technology to examine entire human genome and provide information regarding majority of variation present in individual genome. However, high price associated with whole genome sequencing may impede the segment growth up to certain extent during the forthcoming years.

Direct-to-Consumer  Genetic Testing Market, By Region

North America DTC genetic testing market dominated the global market with more than 38.0% revenue share in 2017 and is expected to witness similar trend over the analysis period. The high growth is attributable to growing incidence of genetic diseases including cancer, neurofibromatosis, spinal muscular atrophy and Turner syndrome in the region. Development of novel tests for prediction of potential allergies, responses to medications as well as risk of cardiovascular and other diseases will augment the demand for DTC genetic testing. Moreover, awareness among people pertaining to their health coupled with favourable regulatory scenario for DTC genetic testing will further foster market growth in the foreseeable future.

Europe market is estimated to show lucrative CAGR of 18.3% over the forecast timeline attributable to rising prevalence of several types of cancers in the region. Hereditary cancer is one of the leading causes of morbidity and mortality in the region. DTC tests help in recognizing genetic predisposition to multiple diseases including cancer, diabetes and Alzheimer’s. Thus, adoption of direct-to-consumer (DTC) tests for early diagnosis and prevention of various genetic diseases should augment the regional growth during the forthcoming years.

Asia Pacific Direct-to-Consumer Genetic Testing Market Size, By Country, 2024 (USD Million)
Asia Pacific DTC Genetic Testing Market Size, By Country, 2024 (USD Million)

Get more details on this report - Request Free Sample PDF

Competitive Market Share

Some of the prominent industry players operational in direct-to-consumer genetic testing market include 23andMe, Ancestry, Color, EasyDNA, Family Tree DNA, Full Genomes, Genesis HealthCare, Helix, Identigene, Karmagenes, Living DNA, MapMyGenome, MyHeritage and Pathway Genomics. Major industry players are primarily focusing on strategies including new product launch, mergers, acquisitions and collaborations to strengthen existing product portfolio and capitalize on market share. For instance, in October 2015, 23andMe announced the launch of Personal Genome Service (PGS), an experience that includes wellness, carrier status, trait and ancestry reports. The strategic move aimed at delivering more tools, insights and better functionality through this service to ensure revenue growth.

Direct-to-Consumer (DTC) Genetic Testing Industry Background

Direct-to-Consumer (DTC) Genetic Testing Market

Get more details on this report - Request Free Sample PDF

The history of direct-to-consumer genetic testing can be traced back to the early 2000s. These tests enabled consumers to access their genetic information without the involvement of a physician. The early models of DTC popular with consumers, were involved in certain medical and regulatory controversies. Few years later, FDA shutdown some DTC genetic testing companies as this type of testing posed certain risks to consumers. Despite of the concerns about clinical and analytical validity of DTC genetic tests, objections to DTC testing based on concerns about consumer anxiety as well as negative changes in health behaviour appeared to be exaggerated. Later, FDA classified DTC genetic carrier screens under lower-risk devices. This opened the way to DTC genetic testing for additional receding conditions in the future. The recent models of DTC genetic testing focus on the need to ensure consumer safety while rendering them potentially beneficial and highly desirable to the consumers. This industry is expected to witness rapid growth in the future owing to growing physician adoption of DTC testing into clinical care coupled with availability of regulatory support for DTC testing and ongoing advancements in technology.???????

What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree